What does the evidence say about Moringa Exercise Performance Randomized Trial?

Updated October 2026

Quick Answer

Moringa Exercise Performance Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: No systematic research critically evaluated its impact on cardiometabolic outcomes assessed through randomized controlled trials (RCTs), thus this study aimed to do so by synthesizing existing evidence.

Key Takeaways

  • 01No systematic research critically evaluated its impact on cardiometabolic outcomes assessed through randomized controlled trials (RCTs), thus this study aimed to do so by synthesizing existing evidence. [Crișan D (2025)]
  • 02Random-effects meta-analyses were performed using standardized mean differences, risk of bias was assessed using the Cochrane RoB 2 tool, while the certainty of evidence was evaluated using GRADE assessment. [Crișan D (2025)]
  • 03Subgroup analyses suggested potential benefits at doses I 2 frequently >80% for anthropometric and lipid parameters), indirectness, and methodological limitations reduced the overall certainty of evidence to very low for all the evaluated outcomes. [Crișan D (2025)]
  • 04is traditionally used in African and Asian medicine for its nutritional and therapeutic properties. [Crișan D (2025)]
The current Migaku evidence database contains 2 reusable source documents for Moringa Exercise Performance Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - No systematic research critically evaluated its impact on cardiometabolic outcomes assessed through randomized controlled trials (RCTs), thus this study aimed to do so by synthesizing existing evidence. [Crișan D (2025); evidence level 1] - Random-effects meta-analyses were performed using standardized mean differences, risk of bias was assessed using the Cochrane RoB 2 tool, while the certainty of evidence was evaluated using GRADE assessment. [Crișan D (2025); evidence level 1] - Subgroup analyses suggested potential benefits at doses I 2 frequently >80% for anthropometric and lipid parameters), indirectness, and methodological limitations reduced the overall certainty of evidence to very low for all the evaluated outcomes. [Crișan D (2025); evidence level 1] - is traditionally used in African and Asian medicine for its nutritional and therapeutic properties. [Crișan D (2025); evidence level 1] - As global life expectancy increases, the incidence of age-associated neurological disorders is expected to rise substantially [,]. [Rahman Muntajin (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effects of <i>Moringa oleifera</i> Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment.
  2. Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis